Literature DB >> 10319210

Epidemiology of the rheumatic diseases.

B K Rooney1, A J Silman.   

Abstract

Epidemiologic studies of rheumatic diseases can be broadly divided into those that describe the occurrence of specific disorders, those that attempt to quantify the role of putative risk factors for disease occurrence, and those that define the outcome and factors associated with it. Studies in this area have tended to be hypothesis testing rather than generating new etiologic or related hypotheses. In contrast to many previously published studies, more recent work has been both substantive in size and focused more on true community-based studies with the consequence that estimates of occurrence in risk obtained are likely to reflect more accurately the true nature of any associations observed.

Entities:  

Mesh:

Year:  1999        PMID: 10319210     DOI: 10.1097/00002281-199903000-00002

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  8 in total

1.  Apparent diffusion coefficient as an indicator of spinal cord compression due to anterior atlanto-axial subluxation in rheumatoid arthritis patients.

Authors:  Małgorzata Mańczak; Grzegorz Pracoń; Iwona Sudoł-Szopińska; Robert Gasik
Journal:  Eur Spine J       Date:  2019-07-12       Impact factor: 3.134

2.  Targeting Oxidative Stress Markers, Xanthine Oxidase, TNFRSF11A and Cathepsin L in Curcumin-Treated Collagen-Induced Arthritis: A Physiological and COSMO-RS Study.

Authors:  Seghira Bisset; Widad Sobhi; Ayoub Attoui; Tarek Lamaoui; Yousef A Bin Jardan; Shobhan Das; Manawwer Alam; Khalil Errahmane Kanouni; Abdelmalek Rezgui; Siham Ferdjioui; Yacine Derradji; Abdelhalim Khenchouche; Yacine Benguerba
Journal:  Inflammation       Date:  2022-10-13       Impact factor: 4.657

Review 3.  Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

Authors:  Katherine A Lyseng-Williamson; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Validation of the Spanish version of a screening questionnaire for the detection of systemic lupus erythematosus.

Authors:  Francisco Javier Aceves-Avila; Martha Alicia Delgadillo-Ruano; César Ramos-Remus; Amparo Gómez-Vargas; Sergio Gutiérrez-Ureña
Journal:  Clin Rheumatol       Date:  2003-11-11       Impact factor: 2.980

5.  Patterns of knee osteoarthritis in a hospital setting in sub-Saharan Africa.

Authors:  Marie Doualla Bija; Henry Namme Luma; Elvis Temfack; Eunice Tafam Gueleko; Fernando Kemta; Madeleine Ngandeu
Journal:  Clin Rheumatol       Date:  2014-06-12       Impact factor: 2.980

6.  Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  Berit M Sverdrup; Henrik Källberg; Lars Klareskog; Lars Alfredsson
Journal:  Arthritis Res Ther       Date:  2012-02-28       Impact factor: 5.156

7.  Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.

Authors:  Berit Sverdrup; Henrik Källberg; Camilla Bengtsson; Ingvar Lundberg; Leonid Padyukov; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Res Ther       Date:  2005-09-23       Impact factor: 5.156

Review 8.  Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis.

Authors:  M A Pineda; L Al-Riyami; W Harnett; M M Harnett
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.